Security Agreement

Recorded: 2009-02-09 Received: 2009-02-09 Pages: 5

Assignor

SCHERING AKTIENGESELLSCHAFT

Executed: 2006-01-04

Assignee

EPIX PHARMACEUTICALS, INC.

161 FIRST STREET, CAMBRIDGE, MA, 02142, UNITED STATES

Covered Properties (5)

Diagnostic imaging contrast agents with extended blood retention

Application: 11/526,312 →

Diagnostic imaging contrast agents with extended blood retention

Application: 11/526,302 →

Diagnostic Imaging Contrast Agents with Extended Blood Retention

Application: 11/472,842 →

Contrast-Enhanced Diagnostic Imaging Method for Monitoring Interventional Therapies

Application: 10/961,872 →

Diagnostic Imaging Contrast Agents with Extended Blood Retention

Application: 10/755,507 →